Trip.com Shares Plummet 6.01% Amid Antitrust Probe, Shareholder Lawsuits as $360M Volume Surges to Rank 495

Market Snapshot

On February 12, 2026, Trip.com Group Limited (TCOM) experienced a 6.01% decline in its stock price, closing at a significant intraday low. Despite the drop, trading activity surged, with a volume of $0.36 billion—up 56.92% from the previous day—placing the stock at rank 495 in overall market trading activity. The divergence between elevated trading volume and downward price movement suggests heightened investor uncertainty or speculative activity in the wake of recent regulatory developments.

Key Drivers

The primary catalyst for TCOM’s recent volatility stems from an ongoing antitrust investigation by China’s State Administration for Market Regulation (SAMR). On January 14, 2026, Trip.com disclosed it had received a formal notice of investigation under the Anti-Monopoly Law of the People’s Republic of China. This revelation triggered an immediate 17.05% plunge in its American Depositary Receipt (ADR) price, closing at $62.78 per ADR. While the February 12 drop of 6.01% reflects a more muted reaction, the cumulative effect of regulatory scrutiny has eroded investor confidence, particularly in a sector where enforcement actions have historically led to material penalties and operational restrictions.

The investigation has also spurred multiple class-action lawsuits from shareholders, with law firms such as Pomerantz LLP and Rosen Law Firm separately announcing inquiries into potential securities fraud or misleading disclosures by Trip.com’s management. These legal actions, though not directly tied to new operational data, amplify market concerns over governance risks and potential financial liabilities. Investors are now evaluating whether the company’s business practices—particularly in pricing algorithms or competitive strategies—could lead to sanctions or restructuring, both of which could weigh on long-term profitability.

Notably, the regulatory and legal pressures coincide with broader macroeconomic challenges in China’s travel sector, which has faced cyclical demand fluctuations and intensified competition. While Trip.com has historically leveraged its dominant market position to expand revenue streams, the current scrutiny raises questions about its ability to maintain margins without regulatory intervention. The lack of concrete updates on the SAMR investigation’s scope or timeline further compounds uncertainty, as investors lack clarity on the potential duration and severity of the probe.

The recent trading patterns—high volume coupled with downward price pressure—indicate that short-term sellers may be capitalizing on regulatory risks, while institutional investors reassess their exposure to the stock. However, the absence of new operational or financial disclosures since the January 14 announcement suggests that the market’s reaction remains anchored to the unresolved nature of the investigation. Analysts will likely monitor future updates from Trip.com or SAMR for signals of resolution, which could either stabilize the stock or exacerbate declines depending on the outcome.

In summary, TCOM’s performance reflects a confluence of regulatory, legal, and sector-specific headwinds. The antitrust probe by SAMR and subsequent shareholder lawsuits have created a toxic mix of compliance risks and reputational damage, overshadowing the company’s operational metrics. Until the investigation’s parameters and implications are clearer, the stock is likely to remain volatile, with further downside risk contingent on the pace of regulatory enforcement in China’s travel technology sector.